drugset / Trial / NCT01530711
Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
NaSingle-groupOpen-labelTreatment
Summary
Observe the effect of terlipressin on renal function in patients with SHR type I adjusting the dose based on hemodynamic response.
Timeline
- Start
- 2012-04
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terlipressin | Peptide | 2 mg | — |
| Background | Albumin | Protein / enzyme biologic | 20 g | — |
| Background | Albumin | Protein / enzyme biologic | 40 g | — |